Viewing Study NCT03787758


Ignite Creation Date: 2025-12-25 @ 12:14 AM
Ignite Modification Date: 2026-02-25 @ 8:19 PM
Study NCT ID: NCT03787758
Status: COMPLETED
Last Update Posted: 2025-09-17
First Post: 2018-12-17
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Study to Evaluate Safety, Tolerability, and Pharmacokinetics of SAGE-718 Oral Solution in Patients With Huntington's Disease - Part B
Sponsor: Supernus Pharmaceuticals, Inc.
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module